APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacology Discovery Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmacology Discovery Service Market Analysis and Forecast 2026-2032

3 May 2026253 pages

Choose your research edition.

Industry ResearchPharmacology Discovery Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacology Discovery Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pharmacology Discovery Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacology Discovery Service Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacology Discovery Service Market Analysis and Forecast 2026-2032253 pages · $4,950 USD

Market perspective

The global Pharmacology Discovery Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmacology Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmacology Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmacology Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmacology Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmacology Discovery Service include Ichor Life Sciences, Inc, NUVISAN, Porsolt, Charles River Laboratories, Eurofins Discovery, Labcorp, BioDuro-Sundia, Creative Biolabs and BRF, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmacology Discovery Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmacology Discovery Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmacology Discovery Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmacology Discovery Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmacology Discovery Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmacology Discovery Service revenue, projected growth trends, production technology, application and end-user industry.

Pharmacology Discovery Service Segment by Company

Ichor Life Sciences, Inc

NUVISAN

Porsolt

Charles River Laboratories

Eurofins Discovery

Labcorp

BioDuro-Sundia

Creative Biolabs

BRF

WuXi AppTec

Dalriada

Sygnature Discovery

Pharmaron

ChemPartner

NuChem Sciences Inc

Genscript ProBio

Pharmacology Discovery Service Segment by Type

In Vivo Disease Model

Cell Based Assays Service

Drug Discovery Service

Others

Pharmacology Discovery Service Segment by Application

Cardiovascular Disease

Eye Diseases

Autoimmune Diseases

Musculoskeletal Diseases

Other

Pharmacology Discovery Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacology Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacology Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacology Discovery Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmacology Discovery Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmacology Discovery Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacology Discovery Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacology Discovery Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. In Vivo Disease Model Major Player Table 3. Cell Based Assays Service Major Player Table 4. Drug Discovery Service Major Player Table 5. Others Major Player Table 6. Global Pharmacology Discovery Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Cardiovascular Disease Major Player Table 8. Eye Diseases Major Player Table 9. Autoimmune Diseases Major Player Table 10. Musculoskeletal Diseases Major Player Table 11. Other Major Player Table 12. Pharmacology Discovery Service Industry Trends Table 13. Pharmacology Discovery Service Industry Drivers Table 14. Pharmacology Discovery Service Industry Opportunities and Challenges Table 15. Pharmacology Discovery Service Industry Restraints Table 16. Global Pharmacology Discovery Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Pharmacology Discovery Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Pharmacology Discovery Service Market Share by Region (2021-2026) Table 19. Global Pharmacology Discovery Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Pharmacology Discovery Service Market Share by Region (2027-2032) Table 21. Global Pharmacology Discovery Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Pharmacology Discovery Service Revenue Market Share by Players (2021-2026) Table 23. Global Pharmacology Discovery Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Pharmacology Discovery Service Key Players Headquarters & Area Served Table 25. Global Pharmacology Discovery Service Players, Product Type & Application Table 26. Global Pharmacology Discovery Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Pharmacology Discovery Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Pharmacology Discovery Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pharmacology Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Pharmacology Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Pharmacology Discovery Service Revenue Market Share by Type (2021-2026) Table 33. Global Pharmacology Discovery Service Revenue Market Share by Type (2027-2032) Table 34. Global Pharmacology Discovery Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pharmacology Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Pharmacology Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Pharmacology Discovery Service Revenue Market Share by Application (2021-2026) Table 38. Global Pharmacology Discovery Service Revenue Market Share by Application (2027-2032) Table 39. Ichor Life Sciences, Inc Company Information Table 40. Ichor Life Sciences, Inc Business Overview Table 41. Ichor Life Sciences, Inc Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Ichor Life Sciences, Inc Pharmacology Discovery Service Product Portfolio Table 43. Ichor Life Sciences, Inc Recent Development Table 44. NUVISAN Company Information Table 45. NUVISAN Business Overview Table 46. NUVISAN Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. NUVISAN Pharmacology Discovery Service Product Portfolio Table 48. NUVISAN Recent Development Table 49. Porsolt Company Information Table 50. Porsolt Business Overview Table 51. Porsolt Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Porsolt Pharmacology Discovery Service Product Portfolio Table 53. Porsolt Recent Development Table 54. Charles River Laboratories Company Information Table 55. Charles River Laboratories Business Overview Table 56. Charles River Laboratories Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Charles River Laboratories Pharmacology Discovery Service Product Portfolio Table 58. Charles River Laboratories Recent Development Table 59. Eurofins Discovery Company Information Table 60. Eurofins Discovery Business Overview Table 61. Eurofins Discovery Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Eurofins Discovery Pharmacology Discovery Service Product Portfolio Table 63. Eurofins Discovery Recent Development Table 64. Labcorp Company Information Table 65. Labcorp Business Overview Table 66. Labcorp Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Labcorp Pharmacology Discovery Service Product Portfolio Table 68. Labcorp Recent Development Table 69. BioDuro-Sundia Company Information Table 70. BioDuro-Sundia Business Overview Table 71. BioDuro-Sundia Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. BioDuro-Sundia Pharmacology Discovery Service Product Portfolio Table 73. BioDuro-Sundia Recent Development Table 74. Creative Biolabs Company Information Table 75. Creative Biolabs Business Overview Table 76. Creative Biolabs Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Creative Biolabs Pharmacology Discovery Service Product Portfolio Table 78. Creative Biolabs Recent Development Table 79. BRF Company Information Table 80. BRF Business Overview Table 81. BRF Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. BRF Pharmacology Discovery Service Product Portfolio Table 83. BRF Recent Development Table 84. WuXi AppTec Company Information Table 85. WuXi AppTec Business Overview Table 86. WuXi AppTec Pharmacology Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. WuXi AppTec Pharmacology Discovery Service Product Portfolio Table 88. WuXi AppTec Recent Development Table 89. Dalriada Company Information Table 90. Dalriada Business Overview Table 91. Dalriada Pharmacology Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Dalriada Pharmacology Discovery Service Product Portfolio Table 93. Dalriada Recent Development Table 94. Sygnature Discovery Company Information Table 95. Sygnature Discovery Business Overview Table 96. Sygnature Discovery Pharmacology Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Sygnature Discovery Pharmacology Discovery Service Product Portfolio Table 98. Sygnature Discovery Recent Development Table 99. Pharmaron Company Information Table 100. Pharmaron Business Overview Table 101. Pharmaron Pharmacology Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Pharmaron Pharmacology Discovery Service Product Portfolio Table 103. Pharmaron Recent Development Table 104. ChemPartner Company Information Table 105. ChemPartner Business Overview Table 106. ChemPartner Pharmacology Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. ChemPartner Pharmacology Discovery Service Product Portfolio Table 108. ChemPartner Recent Development Table 109. NuChem Sciences Inc Company Information Table 110. NuChem Sciences Inc Business Overview Table 111. NuChem Sciences Inc Pharmacology Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. NuChem Sciences Inc Pharmacology Discovery Service Product Portfolio Table 113. NuChem Sciences Inc Recent Development Table 114. Genscript ProBio Company Information Table 115. Genscript ProBio Business Overview Table 116. Genscript ProBio Pharmacology Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Genscript ProBio Pharmacology Discovery Service Product Portfolio Table 118. Genscript ProBio Recent Development Table 119. North America Pharmacology Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Pharmacology Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Pharmacology Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Pharmacology Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Pharmacology Discovery Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Pharmacology Discovery Service Revenue by Country (2021-2026) & (US$ Million) Table 125. North America Pharmacology Discovery Service Revenue by Country (US$ Million) & (2027-2032) Table 126. Europe Pharmacology Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Pharmacology Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Pharmacology Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Pharmacology Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Pharmacology Discovery Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Pharmacology Discovery Service Revenue by Country (2021-2026) & (US$ Million) Table 132. Europe Pharmacology Discovery Service Revenue by Country (US$ Million) & (2027-2032) Table 133. China Pharmacology Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 134. China Pharmacology Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 135. China Pharmacology Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 136. China Pharmacology Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Pharmacology Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Pharmacology Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Pharmacology Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Pharmacology Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Pharmacology Discovery Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Pharmacology Discovery Service Revenue by Region (US$ Million) & (2021-2026) Table 143. Asia Pharmacology Discovery Service Revenue by Region (US$ Million) & (2027-2032) Table 144. SAMEA Pharmacology Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 145. SAMEA Pharmacology Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 146. SAMEA Pharmacology Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 147. SAMEA Pharmacology Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 148. SAMEA Pharmacology Discovery Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. SAMEA Pharmacology Discovery Service Revenue by Country (2021-2026) & (US$ Million) Table 150. SAMEA Pharmacology Discovery Service Revenue by Country (US$ Million) & (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Pharmacology Discovery Service Image Figure 2. Global Pharmacology Discovery Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacology Discovery Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. In Vivo Disease Model Image Figure 5. Cell Based Assays Service Image Figure 6. Drug Discovery Service Image Figure 7. Others Image Figure 8. Global Pharmacology Discovery Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pharmacology Discovery Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Cardiovascular Disease Image Figure 11. Eye Diseases Image Figure 12. Autoimmune Diseases Image Figure 13. Musculoskeletal Diseases Image Figure 14. Other Image Figure 15. Global Pharmacology Discovery Service Market Size (US$ Million) & (2021-2032) Figure 16. Global Pharmacology Discovery Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Pharmacology Discovery Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Pharmacology Discovery Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pharmacology Discovery Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmacology Discovery Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pharmacology Discovery Service Revenue Market Share by Type (2021-2032) Figure 23. Global Pharmacology Discovery Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pharmacology Discovery Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Pharmacology Discovery Service Revenue Market Share by Application (2021-2032) Figure 26. North America Pharmacology Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Pharmacology Discovery Service Revenue Share by Type (2021-2032) Figure 28. North America Pharmacology Discovery Service Revenue Share by Application (2021-2032) Figure 29. North America Pharmacology Discovery Service Revenue Share by Country (2021-2032) Figure 30. United States Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Pharmacology Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Pharmacology Discovery Service Revenue Share by Type (2021-2032) Figure 35. Europe Pharmacology Discovery Service Revenue Share by Application (2021-2032) Figure 36. Europe Pharmacology Discovery Service Revenue Share by Country (2021-2032) Figure 37. Germany Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Pharmacology Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Pharmacology Discovery Service Revenue Share by Type (2021-2032) Figure 47. China Pharmacology Discovery Service Revenue Share by Application (2021-2032) Figure 48. Asia Pharmacology Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Pharmacology Discovery Service Revenue Share by Type (2021-2032) Figure 50. Asia Pharmacology Discovery Service Revenue Share by Application (2021-2032) Figure 51. Asia Pharmacology Discovery Service Revenue Share by Region (2021-2032) Figure 52. Japan Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Pharmacology Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Pharmacology Discovery Service Revenue Share by Type (2021-2032) Figure 60. SAMEA Pharmacology Discovery Service Revenue Share by Application (2021-2032) Figure 61. SAMEA Pharmacology Discovery Service Revenue Share by Country (2021-2032) Figure 62. Brazil Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Pharmacology Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • In Vivo Disease Model
  • Cell Based Assays Service
  • Drug Discovery Service
  • Others
Applications
  • Cardiovascular Disease
  • Eye Diseases
  • Autoimmune Diseases
  • Musculoskeletal Diseases
  • Other
Companies covered
  • Ichor Life Sciences, Inc
  • NUVISAN
  • Porsolt
  • Charles River Laboratories
  • Eurofins Discovery
  • Labcorp
  • BioDuro-Sundia
  • Creative Biolabs
  • BRF
  • WuXi AppTec
  • Dalriada
  • Sygnature Discovery
  • Pharmaron
  • ChemPartner
  • NuChem Sciences Inc
  • Genscript ProBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmacology Discovery Service Market by Type
  3. 1.2.1 Global Pharmacology Discovery Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 In Vivo Disease Model
  5. 1.2.3 Cell Based Assays Service
  6. 1.2.4 Drug Discovery Service
  7. 1.2.5 Others
  8. 1.3 Pharmacology Discovery Service Market by Application
  9. 1.3.1 Global Pharmacology Discovery Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Cardiovascular Disease
  11. 1.3.3 Eye Diseases
  12. 1.3.4 Autoimmune Diseases
  13. 1.3.5 Musculoskeletal Diseases
  14. 1.3.6 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Pharmacology Discovery Service Market Dynamics
  1. 2.1 Pharmacology Discovery Service Industry Trends
  2. 2.2 Pharmacology Discovery Service Industry Drivers
  3. 2.3 Pharmacology Discovery Service Industry Opportunities and Challenges
  4. 2.4 Pharmacology Discovery Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmacology Discovery Service Market Perspective (2021-2032)
  2. 3.2 Global Pharmacology Discovery Service Growth Trends by Region
  3. 3.2.1 Global Pharmacology Discovery Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmacology Discovery Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmacology Discovery Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmacology Discovery Service Revenue by Players
  2. 4.1.1 Global Pharmacology Discovery Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmacology Discovery Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmacology Discovery Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmacology Discovery Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmacology Discovery Service Key Players Headquarters & Area Served
  7. 4.4 Global Pharmacology Discovery Service Players, Product Type & Application
  8. 4.5 Global Pharmacology Discovery Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmacology Discovery Service Market CR5 and HHI
  11. 4.6.3 2025 Pharmacology Discovery Service Tier 1, Tier 2, and Tier 3
5 Pharmacology Discovery Service Market Size by Type
  1. 5.1 Global Pharmacology Discovery Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacology Discovery Service Revenue by Type (2021-2032)
  3. 5.3 Global Pharmacology Discovery Service Revenue Market Share by Type (2021-2032)
6 Pharmacology Discovery Service Market Size by Application
  1. 6.1 Global Pharmacology Discovery Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmacology Discovery Service Revenue by Application (2021-2032)
  3. 6.3 Global Pharmacology Discovery Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Ichor Life Sciences, Inc
  2. 7.1.1 Ichor Life Sciences, Inc Company Information
  3. 7.1.2 Ichor Life Sciences, Inc Business Overview
  4. 7.1.3 Ichor Life Sciences, Inc Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Ichor Life Sciences, Inc Pharmacology Discovery Service Product Portfolio
  6. 7.1.5 Ichor Life Sciences, Inc Recent Developments
  7. 7.2 NUVISAN
  8. 7.2.1 NUVISAN Company Information
  9. 7.2.2 NUVISAN Business Overview
  10. 7.2.3 NUVISAN Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NUVISAN Pharmacology Discovery Service Product Portfolio
  12. 7.2.5 NUVISAN Recent Developments
  13. 7.3 Porsolt
  14. 7.3.1 Porsolt Company Information
  15. 7.3.2 Porsolt Business Overview
  16. 7.3.3 Porsolt Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Porsolt Pharmacology Discovery Service Product Portfolio
  18. 7.3.5 Porsolt Recent Developments
  19. 7.4 Charles River Laboratories
  20. 7.4.1 Charles River Laboratories Company Information
  21. 7.4.2 Charles River Laboratories Business Overview
  22. 7.4.3 Charles River Laboratories Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Charles River Laboratories Pharmacology Discovery Service Product Portfolio
  24. 7.4.5 Charles River Laboratories Recent Developments
  25. 7.5 Eurofins Discovery
  26. 7.5.1 Eurofins Discovery Company Information
  27. 7.5.2 Eurofins Discovery Business Overview
  28. 7.5.3 Eurofins Discovery Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins Discovery Pharmacology Discovery Service Product Portfolio
  30. 7.5.5 Eurofins Discovery Recent Developments
  31. 7.6 Labcorp
  32. 7.6.1 Labcorp Company Information
  33. 7.6.2 Labcorp Business Overview
  34. 7.6.3 Labcorp Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Labcorp Pharmacology Discovery Service Product Portfolio
  36. 7.6.5 Labcorp Recent Developments
  37. 7.7 BioDuro-Sundia
  38. 7.7.1 BioDuro-Sundia Company Information
  39. 7.7.2 BioDuro-Sundia Business Overview
  40. 7.7.3 BioDuro-Sundia Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 BioDuro-Sundia Pharmacology Discovery Service Product Portfolio
  42. 7.7.5 BioDuro-Sundia Recent Developments
  43. 7.8 Creative Biolabs
  44. 7.8.1 Creative Biolabs Company Information
  45. 7.8.2 Creative Biolabs Business Overview
  46. 7.8.3 Creative Biolabs Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Creative Biolabs Pharmacology Discovery Service Product Portfolio
  48. 7.8.5 Creative Biolabs Recent Developments
  49. 7.9 BRF
  50. 7.9.1 BRF Company Information
  51. 7.9.2 BRF Business Overview
  52. 7.9.3 BRF Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BRF Pharmacology Discovery Service Product Portfolio
  54. 7.9.5 BRF Recent Developments
  55. 7.10 WuXi AppTec
  56. 7.10.1 WuXi AppTec Company Information
  57. 7.10.2 WuXi AppTec Business Overview
  58. 7.10.3 WuXi AppTec Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 WuXi AppTec Pharmacology Discovery Service Product Portfolio
  60. 7.10.5 WuXi AppTec Recent Developments
  61. 7.11 Dalriada
  62. 7.11.1 Dalriada Company Information
  63. 7.11.2 Dalriada Business Overview
  64. 7.11.3 Dalriada Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Dalriada Pharmacology Discovery Service Product Portfolio
  66. 7.11.5 Dalriada Recent Developments
  67. 7.12 Sygnature Discovery
  68. 7.12.1 Sygnature Discovery Company Information
  69. 7.12.2 Sygnature Discovery Business Overview
  70. 7.12.3 Sygnature Discovery Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sygnature Discovery Pharmacology Discovery Service Product Portfolio
  72. 7.12.5 Sygnature Discovery Recent Developments
  73. 7.13 Pharmaron
  74. 7.13.1 Pharmaron Company Information
  75. 7.13.2 Pharmaron Business Overview
  76. 7.13.3 Pharmaron Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Pharmaron Pharmacology Discovery Service Product Portfolio
  78. 7.13.5 Pharmaron Recent Developments
  79. 7.14 ChemPartner
  80. 7.14.1 ChemPartner Company Information
  81. 7.14.2 ChemPartner Business Overview
  82. 7.14.3 ChemPartner Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ChemPartner Pharmacology Discovery Service Product Portfolio
  84. 7.14.5 ChemPartner Recent Developments
  85. 7.15 NuChem Sciences Inc
  86. 7.15.1 NuChem Sciences Inc Company Information
  87. 7.15.2 NuChem Sciences Inc Business Overview
  88. 7.15.3 NuChem Sciences Inc Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 NuChem Sciences Inc Pharmacology Discovery Service Product Portfolio
  90. 7.15.5 NuChem Sciences Inc Recent Developments
  91. 7.16 Genscript ProBio
  92. 7.16.1 Genscript ProBio Company Information
  93. 7.16.2 Genscript ProBio Business Overview
  94. 7.16.3 Genscript ProBio Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Genscript ProBio Pharmacology Discovery Service Product Portfolio
  96. 7.16.5 Genscript ProBio Recent Developments
8 North America
  1. 8.1 North America Pharmacology Discovery Service Revenue (2021-2032)
  2. 8.2 North America Pharmacology Discovery Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmacology Discovery Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmacology Discovery Service Revenue by Type (2027-2032)
  5. 8.3 North America Pharmacology Discovery Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmacology Discovery Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmacology Discovery Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmacology Discovery Service Revenue by Application (2027-2032)
  9. 8.5 North America Pharmacology Discovery Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmacology Discovery Service Revenue by Country
  11. 8.6.1 North America Pharmacology Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmacology Discovery Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmacology Discovery Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmacology Discovery Service Revenue (2021-2032)
  2. 9.2 Europe Pharmacology Discovery Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmacology Discovery Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmacology Discovery Service Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmacology Discovery Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmacology Discovery Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmacology Discovery Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmacology Discovery Service Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmacology Discovery Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmacology Discovery Service Revenue by Country
  11. 9.6.1 Europe Pharmacology Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmacology Discovery Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmacology Discovery Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmacology Discovery Service Revenue (2021-2032)
  2. 10.2 China Pharmacology Discovery Service Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmacology Discovery Service Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmacology Discovery Service Revenue by Type (2027-2032)
  5. 10.3 China Pharmacology Discovery Service Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmacology Discovery Service Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmacology Discovery Service Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmacology Discovery Service Revenue by Application (2027-2032)
  9. 10.5 China Pharmacology Discovery Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmacology Discovery Service Revenue (2021-2032)
  2. 11.2 Asia Pharmacology Discovery Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmacology Discovery Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmacology Discovery Service Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmacology Discovery Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmacology Discovery Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmacology Discovery Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmacology Discovery Service Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmacology Discovery Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmacology Discovery Service Revenue by Country
  11. 11.6.1 Asia Pharmacology Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmacology Discovery Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmacology Discovery Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmacology Discovery Service Revenue (2021-2032)
  2. 12.2 SAMEA Pharmacology Discovery Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmacology Discovery Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmacology Discovery Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmacology Discovery Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmacology Discovery Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmacology Discovery Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmacology Discovery Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmacology Discovery Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmacology Discovery Service Revenue by Country
  11. 12.6.1 SAMEA Pharmacology Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmacology Discovery Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmacology Discovery Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst